republic-os/legislation/us/states/va/2026/sb-278.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Federal 340-B Drug Pricing Program; impacts within the Commonwealth.	Drug manufacturers; 340B Drug Pricing Program; work group; report. Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas. The bill requires the work group to submit a report on its findings and recommendations to the Chairs of the Senate Committees on Finance and Appropriations and Education and Health and the House Committees on Appropriations and Health and Human Services by November 1, 2026.	us/states/va	Virginia General Assembly	2026	SB 278	Virginia SB 278 (2026)	bill		enacted	Kannan Srinivasan	7	40	8	2026-01-13	2026-04-13	openstates	ocd-bill/26fec5d8-814d-4502-a490-e36dad19f65e	https://lis.virginia.gov/bill-details/20261/SB278	8e268f60710a600020bf0a9549b05511113088208bd275372c0aeebc01ebf9bb	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia SB 278 (2026) — Federal 340-B Drug Pricing Program; impacts within the Commonwealth.

Drug manufacturers; 340B Drug Pricing Program; work group; report. Directs the Secretary of Health and Human Resources to convene a work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth, with emphasis on governance, transparency, and the availability of pharmacy services in rural and underserved areas. The bill requires the work group to submit a report on its findings and recommendations to the Chairs of the Senate Committees on Finance and Appropriations and Education and Health and the House Committees on Appropriations and Health and Human Services by November 1, 2026.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced (filed) — source
2. Education and Health Substitute (committee substitute) — source
3. Finance and Appropriations Substitute (committee substitute) — source
4. Health Subcommittee Amendment (committee substitute) — source
5. Health and Human Services Amendment (committee substitute) — source
6. House Amendments (committee substitute) — source
7. Enrolled (enrolled) — source

Votes

• H VOTE: — 97–0 (pass) · lower
• Concur House Amendments R — 39–0 (pass) · upper
• Constitutional reading dispensed R — 40–0 (pass) · upper
• Reported from Education and Health with substitute — 9–0 (pass) · upper
• Passage R — 39–0 (pass) · upper
• Reported from Finance and Appropriations with substitute — 15–0 (pass) · upper
• Subcommittee recommends reporting with amendment(s) — 10–0 (pass) · lower
• Reported from Health and Human Services with amendment(s) — 21–0 (pass) · lower

Sponsors

• Kannan Srinivasan — primary (person)
• Barbara A. Favola — cosponsor (person)
• L. Louise Lucas — cosponsor (person)
• Lashrecse D. Aird — cosponsor (person)
• Rodney T. Willett — cosponsor (person)
• Saddam Azlan Salim — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2026-01-13 Prefiled and ordered printed; Offered 01-14-2026 26102079D filing, introduction
• 2026-01-13 Referred to Committee on Education and Health referral-committee
• 2026-01-20 Assigned Education sub: Health referral-committee
• 2026-01-27 Fiscal Impact Statement from Department of Planning and Budget (SB278)
• 2026-01-28 Senate subcommittee offered
• 2026-01-29 Senate committee offered
• 2026-01-29 Reported from Education and Health with substitute and rereferred to Finance and Appropriations (9-Y 0-N 6-A) committee-passage
• 2026-01-30 Committee substitute printed 26106505D-S1 substitution
• 2026-02-11 Reported from Finance and Appropriations with substitute (15-Y 0-N) committee-passage
• 2026-02-12 Rules suspended
• 2026-02-12 Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
• 2026-02-12 Passed by for the day Block Vote (Voice Vote)
• 2026-02-13 Committee substitute printed 26107756D-S2 substitution
• 2026-02-13 Read second time reading-2
• 2026-02-13 Committee substitute rejected (Voice Vote)
• 2026-02-13 Committee substitute agreed to (Voice Vote) substitution
• 2026-02-13 Engrossed by Senate - committee substitute (Voice Vote) substitution
• 2026-02-16 Read third time and passed Senate (39-Y 0-N 0-A) passage, reading-3
• 2026-02-19 Placed on Calendar
• 2026-02-19 Read first time reading-1
• 2026-02-19 Referred to Committee on Health and Human Services referral-committee
• 2026-02-23 Assigned sub: Health referral-committee
• 2026-02-23 Fiscal Impact Statement from Department of Planning and Budget (SB278)
• 2026-02-24 House subcommittee offered
• 2026-02-24 Subcommittee recommends reporting with amendment(s) (10-Y 0-N)
• 2026-02-26 Reported from Health and Human Services with amendment(s) (21-Y 0-N) committee-passage
• 2026-03-02 Read second time reading-2
• 2026-03-03 Read third time reading-3
• 2026-03-03 committee amendments agreed to amendment-passage
• 2026-03-03 Engrossed by House as amended
• 2026-03-03 Passed House with amendments (97-Y 0-N 0-A) passage
• 2026-03-05 House amendments agreed to by Senate (39-Y 0-N 0-A) amendment-passage
• 2026-03-11 Enrolled enrolled
• 2026-03-11 Bill text as passed Senate and House (SB278ER) passage
• 2026-03-11 Fiscal Impact Statement from Department of Planning and Budget (SB278)
• 2026-03-11 Signed by President passage
• 2026-03-12 Signed by Speaker passage
• 2026-03-14 Enrolled Bill communicated to Governor on March 14, 2026 enrolled, executive-receipt
• 2026-03-14 Governor's Action Deadline 11:59 p.m., April 13, 2026 executive-receipt
• 2026-04-13 Approved by Governor-Chapter 887 (effective 7/1/2026) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/26fec5d8-814d-4502-a490-e36dad19f65e. Confidence: reported (aggregated from official Virginia legislature records).